Cardeon Formulations Private Limited
About Cardeon Formulations Private Limited
Data last updated:
Cardeon Formulations Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 31 August 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2005PTC057367. Its GSTIN is 33AACCC7536N1ZF (Tamil Nadu).
The company has an authorised share capital of ₹8 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Srinivasan Chandrasekaran and Ramakrishnan Chandrashekar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1/599 Plot No 4 B Flat E Ground Floor 5th Street Karthikeyapuram Madipakkam, Chennai, Tamil Nadu, India – 600091.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.18 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹5.53 Lakh (net margin 4.7%) and EBITDA of ₹7.66 Lakh (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 4% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹32.28 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address1/599 Plot No 4 B Flat E Ground Floor 5th Street Karthikeyapuram Madipakkam, Chennai, Tamil Nadu, India – 600091
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Cardeon Formulations Private Limited
The main business activity of Cardeon Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cardeon Formulations Private Limited FY 2025 filings available
Cardeon Formulations Private Limited reported revenue of ₹1.18 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Cardeon Formulations Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 9% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Cardeon Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.66 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.53 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cardeon Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cardeon Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Cardeon Formulations Private Limited
Cardeon Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atyanat Pharmaceuticals India Private Limited | ₹1.18 Cr (FY 2023) | •••• | •••• | •••• | Dehradun, Uttarakhand, India | |
| Herbidus Formulations Private Limited | ₹1.18 Cr (FY 2025) | •••• | •••• | 79.0% | •••• | Delhi, India |
| Curactive Life Sciences Private Limited | ₹1.18 Cr (FY 2023) | •••• | •••• | 769.0% | •••• | Vadodara, Gujarat, India |
| Dexter Formulation Private Limited | ₹1.18 Cr (FY 2025) | •••• | •••• | -32.0% | •••• | Mayialduthurai, Tamil Nadu, India |
| M J Exports Private Limited | ₹1.18 Cr (FY 2025) | •••• | •••• | -28.0% | •••• | Mumbai, Maharashtra, India |
| Cardeon Formulations Private Limited this company | ₹1.18 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Chennai, Tamil Nadu, India |
| Sentalin Pharmaceuticals Private Limited | ₹1.18 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Mumbai, Maharashtra, India |
| Xperia Healthcare Private Limited | ₹1.18 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Vasai, Maharashtra, India |
| Life Care Heritage Formulations Private Limited | ₹1.18 Cr (FY 2025) | •••• | •••• | -65.0% | •••• | Hyderabad, Telangana, India |
| Incarnate Pharmachem Private Limited | ₹1.17 Cr (FY 2018) | •••• | •••• | -31.0% | •••• | Ahmedabad, Gujarat, India |
| Torando Lifevision Private Limited | ₹1.17 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Cardeon Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Cardeon Formulations Private Limited
Cardeon Formulations Private Limited is audited by M S PANDIAN for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M S PANDIAN | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Cardeon Formulations Private Limited
Cardeon Formulations has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasan Chandrasekaran | Director | 31 Aug 2005 | 21 Years 1 Months | Current |
| Ramakrishnan Chandrashekar | Director | 31 Aug 2005 | 21 Years 1 Months | Current |
Ownership and Shareholding of Cardeon Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cardeon Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Dec 2016 | State Bank of India | ₹6.14 Lakh | Satisfied |
| 14 Dec 2016 | State Bank of India | ₹6.14 Lakh | Satisfied |
| 05 Jun 2006 | State Bank of India | ₹20 Lakh | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Cardeon Formulations Private Limited
Cardeon Formulations Private Limited has a workforce of 3 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cardeon Formulations Private Limited
Cardeon Formulations Private Limited has 3 board changes on record since 2005: 2 appointments and 1 cessation. The latest: Chinnathambi Paramasivan ceased to be Director on 04 Jul 2007.
Credit Ratings, Litigation & Regulatory Alerts for Cardeon Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cardeon Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cardeon Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cardeon Formulations Private Limited
Cardeon Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AACCC7536N1ZF | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cardeon Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cardeon Formulations Private Limited
Cardeon Formulations is an active private limited company based in Chennai, Tamil Nadu, India. The company works in chemical products, within the chemicals industry. It was incorporated on 31 August 2005 (21+ years old) and is registered under CIN U24231TN2005PTC057367.
Cardeon Formulations reported revenue of ₹1.18 Cr for FY 2025 (up 9% YoY).
Cardeon Formulations has 2 current directors:
- Srinivasan Chandrasekaran - Director
- Ramakrishnan Chandrashekar - Director
Cardeon Formulations reported a net profit of ₹5.53 Lakh (net margin 4.7%) and EBITDA of ₹7.66 Lakh (EBITDA margin 6.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Cardeon Formulations is 6% over three years and 4% over five years. In the latest year (FY 2025) revenue rose 9%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Cardeon Formulations is 33AACCC7536N1ZF, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Cardeon Formulations is U24231TN2005PTC057367. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cardeon Formulations was incorporated on 31 August 2005, making it 21+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Cardeon Formulations by revenue are Atyanat Pharmaceuticals India Private Limited, Herbidus Formulations Private Limited, Curactive Life Sciences Private Limited, Dexter Formulation Private Limited, M J Exports Private Limited and 5 more, all in the Pharma industry (Formulations).
Chinnathambi Paramasivan ceased to be Director on 04 Jul 2007. Ramakrishnan Chandrashekar was appointed as Director on 31 Aug 2005. Srinivasan Chandrasekaran was appointed as Director on 31 Aug 2005.
The registered office of Cardeon Formulations is at 1599 Plot No 4 B Flat E Ground Floor 5th Street Karthikeyapuram Madipakkam, Chennai, Tamil Nadu, India – 600091.